On Wednesday this week, the major insulin manufacturer Eli Lilly announced their plan to cut their price of insulin by 70% and to cap out-of-pocket expenses at $35 per month. This price cut follows calls by some politicians to tackle medical costs. See how different narratives in the U.S. media are responding to the issue of insulin in this Kudzu brief.
Least-bias and center-leaning sources have dominated, with almost 5x as many sources. Also, left-leaning sources nearly double right-leaning sources.